Linden Thomas Advisory Services’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.54M Buy
47,314
+1,368
+3% +$140K 0.37% 62
2026
Q1
$5.02M Buy
45,946
+10,901
+31% +$1.04M 0.48% 43
2025
Q4
$2.84M Buy
35,045
+54
+0.2% +$4.65K 0.29% 95
2025
Q3
$3.06M Buy
34,991
+438
+1% +$39.1K 0.31% 82
2025
Q2
$2.87M Sell
34,553
-1,038
-3% -$86.7K 0.32% 86
2025
Q1
$2.99M Buy
35,591
+1,109
+3% +$103K 0.39% 62
2024
Q4
$3.18M Buy
34,482
+1,834
+6% +$176K 0.4% 53
2024
Q3
$3.03M Buy
32,648
+1,088
+3% +$94.3K 0.41% 50
2024
Q2
$2.6M Buy
31,560
+1,034
+3% +$76K 0.4% 56
2024
Q1
$2.03M Buy
30,526
+530
+2% +$32.7K 0.33% 89
2023
Q4
$1.7M Buy
29,996
+839
+3% +$44K 0.32% 108
2023
Q3
$1.59M Buy
29,157
+568
+2% +$33.7K 0.35% 89
2023
Q2
$1.92M Buy
+28,589
New +$1.74M 0.43% 55

Other funds holding LMAT

Linden Thomas Advisory Services's LMAT Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its LeMaitre Vascular (LMAT) stake by 3% in Q2 2026, buying an estimated $140K and bringing the position to 47,314 shares worth $4.54M. The position accounts for 0.37% of the portfolio, ranked #62.

Linden Thomas Advisory Services first reported a position in LMAT in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.02M in Q1 2026. 32 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Linden Thomas Advisory Services held 47,314 shares of LeMaitre Vascular worth $4.54M as of Q2 2026.
  • Linden Thomas Advisory Services bought 1,368 LeMaitre Vascular shares in Q2 2026, an estimated $140K.
  • LeMaitre Vascular made up 0.37% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #62 holding.
  • Linden Thomas Advisory Services first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 13 quarters since.
  • Linden Thomas Advisory Services's LeMaitre Vascular position peaked at $5.02M in Q1 2026.
  • 32 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.